NCT03595267 Kidney Check: Diabetes, Blood Pressure & Kidney Health Checks & Care in Indigenous Communities.
| NCT ID | NCT03595267 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Manitoba |
| Condition | Chronic Kidney Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2019-10-01 |
| Primary Completion | 2025-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2019-10-01 with a primary completion date of 2025-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Faced with limited access to preventative health care services, Indigenous people living in rural and remote communities are at a higher risk of Chronic Kidney Disease (CKD) and kidney failure, when compared to the general population. The goal of this project is to perform point-of-care testing for CKD and its risk factors, including diabetes and high blood pressure, for individuals residing in rural and remote Indigenous communities across the Canadian provinces of Manitoba, British Columbia, Alberta, Saskatchewan, and Ontario. In addition to providing individuals with information about their risk of developing CKD, as well as providing tailored treatment plans, this study will help provide evidence to develop a permanent CKD surveillance system in all Indigenous communities across Canada, consequently decreasing the burden of CKD and kidney failure in these communities.
Eligibility Criteria
Inclusion Criteria: * All individuals aged 10 years old - 80 years old will be recruited for screening, regardless of known CKD risk factors, such as diabetes, elevated blood pressure, or family history of kidney disease. Exclusion Criteria: * None.
Contact & Investigator
Paul Komenda, MD MHA
PRINCIPAL INVESTIGATOR
University of Manitoba
Frequently Asked Questions
Who can join the NCT03595267 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 80 Years, studying Chronic Kidney Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03595267 currently recruiting?
Yes, NCT03595267 is actively recruiting participants. Contact the research team at mjames4@sogh.mb.ca for enrollment information.
Where is the NCT03595267 trial being conducted?
This trial is being conducted at Calgary, Canada, West Vancouver, Canada, Winnipeg, Canada.
Who is sponsoring the NCT03595267 clinical trial?
NCT03595267 is sponsored by University of Manitoba. The principal investigator is Paul Komenda, MD MHA at University of Manitoba. The trial plans to enroll 2,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.